Aurora Cannabis (ACB) Non Operating Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Non Operating Income of -$34272.7 for Q1 2026, up 99.67% year-on-year from -$17164.4 in Q1 2025, and up 93.2% on a QoQ basis from -$504111.7 in Q4 2025.
Aurora Cannabis (ACB) Non Operating Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Non Operating Income for 10 consecutive years, with -$34272.7 the latest figure, recorded in Q1 2026.
- Quarterly Non Operating Income rose 99.67% year-over-year to -$34272.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (up 59.81% YoY) and the FY2026 annual result came in at $520998.9, up 103.38% from the prior year.
- Non Operating Income grew to -$34272.7 in Q1 2026 per ACB's latest filing, from -$504111.7 in the prior quarter.
- Over the last five years, Non Operating Income for ACB reached as high as $742.1 million in Q1 2022 and fell as low as -$11.7 million in Q2 2022.
- A 5-year average of $48.9 million and a median of -$1.3 million in 2025 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income surged 5628.28% — and 2025, when it slumped 156.04%.
- Year by year, Non Operating Income stood at $5.7 million in 2022, then slumped by 103.48% to -$199000.0 in 2023, then soared by 2522.61% to $4.8 million in 2024, then sank by 110.46% to -$504111.7 in 2025, then soared by 93.2% to -$34272.7 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$34272.7, -$504111.7, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | -34,272.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,272.67 |
| Dec 31, 2025 | -504,111.66 |
| Sep 30, 2025 | -1.61 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | -10.49 Mn |
| Dec 31, 2024 | 4.82 Mn |
| Sep 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | 18.72 Mn |
| Dec 31, 2023 | -199,000.00 |
| Sep 30, 2023 | -3.06 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Sep 30, 2022 | -6.28 Mn |
| Jun 30, 2022 | -11.71 Mn |
| Mar 31, 2022 | 742.10 Mn |
| Dec 31, 2021 | -12.62 Mn |
| Sep 30, 2021 | 34.28 Mn |
| Jun 30, 2021 | -298.10 Mn |
| Mar 31, 2021 | -13.42 Mn |
| Dec 31, 2020 | -14.48 Mn |